Development of spin-labeled probes for adenosine receptors

Journal of Medicinal Chemistry

Volumn 48, Issue 6, 2005, Pages 2108-2114

  Ilaš, Janez ^a,b   Pečar, Slavko ^b,c   Hockemeyer, Jörg ^a   Euler, Harald ^a   Kirfel, Armin ^a   Müller, Christa E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

8 (1 OXYL 2,2,5,5 TETRAMETHYL 2,5 DIHYDRO 1H PYRROL 3 YL) 1,3 DIPROPYLXANTHINE; 8 [4 (((1 OXYL 2,2,6,6 TETRAMETHYLPIPERIDIN 4 YL)AMINO) 2 OXOETHOXY)PHENYL] 1 PROPYLXANTHINE; 8 CYCLOPENTYL 3 (1 OXYL 2,2,5,5 TETRAMETHYL 2,5 DIHYDRO 1H PYRROL 3 YLMETHYL 1 PROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; NITROXIDE DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON PROBE MICROANALYSIS; ELECTRON SPIN RESONANCE; HUMAN; MECHANICAL PROBE; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SPIN LABELING; X RAY ANALYSIS;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CELL LINE; CRICETINAE; CRICETULUS; CRYSTALLOGRAPHY, X-RAY; CYCLIC N-OXIDES; CYCLOPENTANES; HUMANS; LIGANDS; MOLECULAR STRUCTURE; RADIOLIGAND ASSAY; RATS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2B; RECEPTORS, PURINERGIC P1; SPIN LABELS; STRUCTURE-ACTIVITY RELATIONSHIP; XANTHINES;

EID: 15444364191     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049513x     Document Type: Article

References (35)

1. Fredholm, B. B.; IJzerman, A. P.; Jacobson, K. A.; Klotz, K. N.; Linden, J. International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors. Pharmacol. Rev. 2001, 53, 527-552.
2. Klotz, K. N. Adenosine receptors and their ligands. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 362, 382-391.
3. Baraldi, P. G.; Cacciari, B.; Borea, P. A.; Varani, K.; Pastorin, G.; Da Ros, T.; Tabrizi, M. A.; Fruttalo, F.; Spallutto, G. Pyrazolo-Triazolo- Pyrimidine Derivatives as Adenosine Receptor Antagonists: A Possibile Template for Adenosine Receptor Subtypes? Curr. Pharm. Des. 2002, 8, 2299-2332.
4. 1-Adenosine receptor antagonists. Exp. Opin. Ther. Parents 1997, 7, 419-440.
5. Luecke, H.; Schobert, B.; Richter, H. T.; Cartailler, J. P.; Lanyi, J. K. Structure of bacteriorhodopsin at 1.55 resolution. J. Mol. Biol. 1999, 29, 889-911.
6. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000, 289, 739-745.
7. 1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. J. Biol. Chem. 1992, 267, 10764-10777.
8. 2A adenosine receptor. J. Biol. Chem. 1995, 270, 13987-13997.
9. Holschbach, M. H.; Olsson, R. A. Applications of adenosine receptor ligands in medical imaging by positron emission tomography. Curr. Pharm. Des. 2002, 8, 2345-2352.
10. Hatanaka, Y.; Sadakane, Y. Photoaffinity labeling in drug discovery and developments: chemical gateway for entering proteomic frontier. Curr. Top. Med. Chem. 2002, 2, 271-288.
11. Freudenthal, S. J. Fluorophordesign und Fluoreszenzmarkierung: Synthese funktionalisierter BODIPY-Derivate und Markierung von Purinrezeptor-Liganden (Fluorophor design and fluorescence labeling: synthesis of functionalized BODIPY derivatives and labeling of purine receptor ligands). Dissertation thesis, Pharmaceutical Institute, University of Bonn (Germany), 2002; http://hss.ulb.uni-bonn.de/ulb_bonn/diss_online/math_nat-_fak/2002/ freudenthal_sven_jan/.
12. Briddon, S. J.; Middleton, R. J. Cordeaux, Y.; Flavin, F. M.; Weinstein, J. A.; George, M. W.; Kellam, B.; Hill, S. J. Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells. Proc. Natl. Acad. Sci. 2004, 101, 4673-4678.
13. Berliner, L. J. Spin Labeling II. Theory and Applications; Academic Press: New York, 1979.
14. Štalc, A.; Šentjurc, M.; Pečar, S. On the topography of the active center of acetylcholinesterase. Vestn. Slov. Kem. Drus. 1992, 39, 243-257.
15. Grubič, Z.; Štalc, A.; Šentjurc, M.; Pečar, S.; Gentry, K. M.; Doctor, B. P. Different effects of two peripheral anion site-binging ligand on the acetylcholinesterase active-site gorge topography revealed by electron paramagnetic resonace. Biochim. Biophys. Acta 1995, 1249, 155-160.
16. Šentjurc, M.; Pečar, S.; Stojan, J.; Marchot, P.; Radič, Z.; Grubič, Z. Electron paramagnetic resonace reveals altered active center gorge of acetylcholinesterase after binding to fasculin to the peripheral site. Biochim. Biophys. Acta 1999, 38856, 349-358.
17. Sussman, L.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Atomic structure of acetylcholinesterase from Torpedo californica, a prototypic acetylcholine-binding protein. Science 1991, 253, 872-879.
18. Rosantsev, E. G. Free Nitroxyl Radicals; Plenum Press: New York, 1970.
19. 2B adenosine receptors. Curr. Top. Med. Chem. 2003, 3, 427-443.
20. 2B Adenosine Receptor Antagonists. J. Med. Chem. 2002, 45, 1500-1510.
21. Müller, C. E. General Synthesis and Properties of 1-Monosubstituted Xanthines. Synthesis 1993, 1, 125-128.
22. Weyler, S.; Hayallah, A. M.; Müller, C. E. Versatile, convenient synthesis of pyrimido[1,2,3-cd]purinediones. Tetrahedron 2003, 59, 47-54.
23. Hankovszky, H. O.; Hideg, K.; Lex, L. Nitroxyls; VII. Synthesis and Reactions of Highly Reactive 1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydropyrrol-3- ylmethyl Sulfonates. Synthesis 1980, 11, 914-916.
24. 2A Adenosine Receptor Antagonists with 8-Styrylxanthine Structure: Potential Drugs for Parkinson's Disease. J. Org. Chem. 2004, 69, 3308-3318.
25. Hankovszky, H. O.; Hideg, K.; Tigyi, J. Nitroxides. II. 1-Oxyl-4-carboxyl-2,2,5,5-tetramethylpyrroline-3-carboxilic Acid Derivatives. Acta Chim. Hung. 1978, 98, 339-348.
26. Hideg, K.; Hankovszky, H. O.; Lex, L.; Kulcsar, G. Nitroxyls; VI. Synthesis and Reactions of 3-Hydroxymethyl-2,2,5,5-tetramethyl-2,5- dihydropyrrole-l-oxyl and 3-Formyl Derivatives. Synthesis 1980, 11, 911-913.
27. Rauckman, E. J.; Rosen, G. M.; Abou-Donia, M. B. Synthesis of a Useful Spin Labeled Probe, 1-Oxyl-4-carboxyl-2,2,6,6-tetramethylpiperidine. J. Org. Chem. 1976, 41, 564-565.
28. Raikova, E. T.; Demirov, G. D.; Kafalieva T. N. Synthesis, properties and biological activity of 4-ethylcarbonylamino-2,2,6,6-tetramethyliperidine-1- oxyl. Dokl. Bolg. Acad. Nauk. 1982, 35, 689-691.
29. Müller, C. E. Adenosinrezeptor-Antagonisten: Synthese, in-vitro-Testung, Struktur-Wirkungs-Beziehungen. Habilitation thesis, Pharmaceutical Institute Tübingen (Germany), 1994.
30. Yan, L.; Müller, C. E. Preparation, Properties, Reactions, and Adenosine Receptor Affinities of Sulfophenylxanthine Nitrophenyl Esters: Toward the Development of Sulfonic Acid Prodrugs with Peroral Bioavailability. J. Med. Chem. 2004, 47, 1031-1043.
31. 2A-selective adenosine receptor antagonists. J. Med. Chem. 2000, 43, 440-448.
32. 2A adenosine receptors. Eur. J. Pharm. Sci. 2000, 1, 259-265.
33. 3 adenosine receptors. Bioorg. Med. Chem. Lett. 2002, 12, 501-503.
34. 2B-selective adenosine receptor antagonists. J. Med. Chem. 2002, 45, 1500-1510.
35. 3 adenosine receptors. Bioorg. Med. Chem. 2003, 11, 347-356.